e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
COPD: exacerbations, gas exchange and associated dysfunction
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD
Iwona Damps-Konstanska (Gdynia, Poland), Iwona Damps-Konstanska, Katarzyna Puzniakowska, Marta Gruchala-Niedoszytko, Michal Makowiecki, Katarzyna Swietnicka, Ewa Jassem
Source:
International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Session:
COPD: exacerbations, gas exchange and associated dysfunction
Session type:
Thematic Poster Session
Number:
669
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Iwona Damps-Konstanska (Gdynia, Poland), Iwona Damps-Konstanska, Katarzyna Puzniakowska, Marta Gruchala-Niedoszytko, Michal Makowiecki, Katarzyna Swietnicka, Ewa Jassem. Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD. Eur Respir J 2015; 46: Suppl. 59, 669
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts)
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Relation betweeen vitamin D levels and clinical properties of COPD patients
Source: International Congress 2015 – Different data in COPD
Year: 2015
Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
The relationship between systemic inflammation and vitamin D levels in COPD
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
The effect of Vitamin D deficiency on lung function in current smoker COPD patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD
Source: International Congress 2014 – Predictors
Year: 2014
Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Vitamin D deficiency is associated with rapid decline in exercise capacity in male patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Profile of serum vitamin D levels in stable COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Serum sirtuin-1 is reduced in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept